Posted by Michael Wonder on 20 Apr 2021
Health economic assessment of Darzalex in multiple myeloma
19 April 2021 - TLV has produced a health economic assessment for the regions for the drug Darzalex in combination with bortezomib, melphalan and prednisone.
The evaluation concerns the treatment of adult patients with newly diagnosed multiple myeloma and who are not suitable for so-called autologous stem cell transplantation.
